Search Results - "ELLIS, Ruth D"
-
1
Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51
Published in PloS one (09-07-2008)“…Pfs25 and Pvs25, surface proteins of mosquito stage of the malaria parasites P. falciparum and P. vivax, respectively, are leading candidates for vaccines…”
Get full text
Journal Article -
2
Phase 1 study in malaria naïve adults of BSAM2/Alhydrogel®+CPG 7909, a blood stage vaccine against P. falciparum malaria
Published in PloS one (04-10-2012)“…A Phase 1 dose escalating study was conducted in malaria naïve adults to assess the safety, reactogenicity, and immunogenicity of the blood stage malaria…”
Get full text
Journal Article -
3
Combining Viral Vectored and Protein-in-adjuvant Vaccines Against the Blood-stage Malaria Antigen AMA1: Report on a Phase 1a Clinical Trial
Published in Molecular therapy (01-12-2014)“…The development of effective vaccines against difficult disease targets will require the identification of new subunit vaccination strategies that can induce…”
Get full text
Journal Article -
4
Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria
Published in PloS one (13-08-2008)“…Apical Membrane Antigen 1 (AMA1), a polymorphic merozoite surface protein, is a leading blood-stage malaria vaccine candidate. This is the first reported use…”
Get full text
Journal Article -
5
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali
Published in Vaccine (18-05-2009)“…Abstract A double blind, randomized, controlled Phase 2 clinical trial was conducted to assess the safety, immunogenicity, and biologic impact of the vaccine…”
Get full text
Journal Article -
6
Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in malaria naïve adults
Published in PloS one (22-01-2010)“…Merozoite surface protein 1(42) (MSP1(42)) is a leading blood stage malaria vaccine candidate. In order to induce immune responses that cover the major…”
Get full text
Journal Article -
7
Can growth inhibition assays (GIA) predict blood-stage malaria vaccine efficacy?
Published in Human vaccines & immunotherapeutics (01-06-2012)“…An effective vaccine against P. falciparum malaria remains a global health priority. Blood-stage vaccines are an important component of this effort, with some…”
Get full text
Journal Article -
8
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
Published in Malaria journal (21-06-2010)“…Extensive genetic diversity in vaccine antigens may contribute to the lack of efficacy of blood stage malaria vaccines. Apical membrane antigen-1 (AMA1) is a…”
Get full text
Journal Article -
9
A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel® + CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults
Published in Vaccine (09-12-2009)“…Abstract A double blind, randomized and controlled Phase 1 clinical trial was conducted to assess the safety and immunogenicity in malaria-exposed adults of…”
Get full text
Journal Article -
10
The TLR9 Ligand CpG Promotes the Acquisition of Plasmodium falciparum-Specific Memory B Cells in Malaria-Naive Individuals
Published in The Journal of immunology (1950) (01-03-2009)“…Despite the central role of memory B cells (MBC) in protective immune responses, little is understood about how they are acquired in naive individuals in…”
Get full text
Journal Article -
11
Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In Vitro Growth Inhibition Assay
Published in Clinical and Vaccine Immunology (01-07-2009)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
12
Blood stage vaccines for Plasmodium falciparum: Current status and the way forward
Published in Human vaccines (01-08-2010)“…Since the recent call for a shift from malaria control to eradication, the role of asexual blood stage vaccines for falciparum malaria, which are not expected…”
Get full text
Journal Article -
13
The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum -specific memory B cells in semi-immune adults in Mali
Published in Vaccine (09-12-2009)“…Abstract Antibodies play a key role in controlling blood stage malaria infections, and an effective blood stage malaria vaccine will likely require that it…”
Get full text
Journal Article -
14
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
Published in The New England journal of medicine (12-07-2018)“…In this phase 2 study, investigators evaluated the potential of two vaccines (H4:IC31 and BCG) to prevent the acquisition of tuberculosis infection and the…”
Get full text
Journal Article -
15
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults
Published in PloS one (2016)“…Transmission-blocking vaccines (TBVs) that target sexual stage parasite development could be an integral part of measures for malaria elimination. Pfs25 is a…”
Get full text
Journal Article -
16
Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children
Published in PloS one (13-02-2008)“…Apical Membrane Antigen-1 (AMA1) is one of the leading blood stage malaria vaccine candidates. AMA1-C1/Alhydrogel consists of an equal mixture of recombinant…”
Get full text
Journal Article -
17
Non-apical membrane antigen 1 (AMA1) IgGs from Malian children interfere with functional activity of AMA1 IgGs as judged by growth inhibition assay
Published in PloS one (13-06-2011)“…Apical membrane antigen 1 (AMA1) is one of the best-studied blood-stage malaria vaccine candidates. When an AMA1 vaccine was tested in a malaria naïve…”
Get full text
Journal Article -
18
Comparing the Understanding of Subjects Receiving a Candidate Malaria Vaccine in the United States and Mali
Published in The American journal of tropical medicine and hygiene (01-10-2010)“…Initial responses to questionnaires used to assess participants' understanding of informed consent for malaria vaccine trials conducted in the United States…”
Get full text
Journal Article -
19
Anaemia in a phase 2 study of a blood stage falciparum malaria vaccine
Published in Malaria journal (19-01-2011)“…A Phase 1-2b study of the blood stage malaria vaccine AMA1-C1/Alhydrogel was conducted in 336 children in Donéguébougou and Bancoumana, Mali. In the Phase 2…”
Get full text
Journal Article -
20
Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube
Published in Clinical infectious diseases (30-10-2019)“…Early secretory antigenic target-6 (ESAT-6) is an immunodominant Mycobacterium tuberculosis (M.tb) antigen included in novel vaccines against tuberculosis (TB)…”
Get full text
Journal Article